Ascendia to Highlight How to Make Insoluble Soluble During CPhI North America

Jul 20, 2021 12:00:00 AM

cGMP vs GMP: What’s the Difference?

Jul 19, 2021 12:00:00 AM

CDMO Selection Criteria: 4 Factors to Consider

Jul 12, 2021 12:00:00 AM

Formulation Forum: Nanosuspension Dosage Forms

Jul 6, 2021 12:00:00 AM

4 Factors Affecting Solubility of Drugs

Jul 5, 2021 12:00:00 AM

Ascendia to Conduct Virtual Meetings During DCAT Week

Jul 1, 2021 12:00:00 AM

Solved: What Is a CDMO (and Why Do You Need One)?

Jun 30, 2021 12:00:00 AM

Meet Ascendia at BIO 2021 – Industry’s Top Networking Virtual Show

Jun 8, 2021 12:00:00 AM

Leading Pharma, Biopharma Industry Report Features Ascendia

May 24, 2021 12:00:00 AM

Factors to Consider When Selecting a CDMO for Complex Injectables Development and Manufacture

May 3, 2021 12:00:00 AM

Ascendia Pharmaceuticals Secures Growth Equity Investment from Signet Healthcare Partners

Apr 8, 2021 12:00:00 AM

Ascendia Overcomes Multiple Challenges to Successfully Formulate Compound for Pharma Company

Mar 25, 2021 12:00:00 AM